Aledade Partners Drive Superior Hypertension Outcomes Through Innovation and Preventive Care The challenge of managing hypertension continues to loom large over modern healthcare systems, particularly in the United States, where heart disease remains the leading cause of death. Nearly half…
GE HealthCare to Lead Major EU IHI Consortium Advancing Cardio-Oncology Care The global healthcare landscape is undergoing a profound transformation, driven by rapid technological advancements and an increasing focus on personalized, preventive care. One of the most critical intersections in…
GetHealthy Launches Script, an AI-Powered Platform Expanding Practitioner Commerce Across Seven Product Categories Beyond Supplements GetHealthy, a company focused on enabling practitioner-driven health commerce, has introduced a new platform called GetHealthy Script—an AI-enabled clinical scripting solution designed to transform how…
Alpha Cognition Reports Strong Fiscal 2025 Results, Highlights Growing Momentum for ZUNVEYL and Strategic Progress Toward Profitability Alpha Cognition ,a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, has reported its financial results for the fourth quarter and…
Projects $170 Million EBITDA Improvement and Path to Profitability in 2026 P3 Health Partners a physician-led and patient-centered population health management organization, has released its financial results for the fourth quarter and full year ending December 31, 2025, while also…
Pediatrix Partners with Tennessee Maternal-Fetal Medicine to Expand Maternal Care Services Pediatrix Medical Group, Inc., a prominent provider of physician services across the United States, has announced a strategic expansion of its maternal health services in Middle Tennessee through a…
Driving AI-powered early detection, risk prediction, and integrated care pathways to improve cardiovascular outcomes for cancer patients and survivors across Europe. The newly launched COMPASS consortium represents one of the most ambitious and strategically important public-private collaborations under the European…
Agenus to Host March 2026 Webcast on Advancing BOT+BAL Immunotherapy and Expanding Patient Access Agenus , a biotechnology company at the forefront of immuno-oncology innovation, has announced that it will host its March 2026 Stakeholder Webcast, continuing its efforts to…
Rubedo Life Sciences Reports Encouraging Phase I Results for RLS-1496 in Plaque Psoriasis, Atopic Dermatitis, and Aging Skin Rubedo Life Sciences, a clinical-stage biotechnology company focused on developing innovative therapies targeting cellular aging, has reported encouraging preliminary findings from its…
FDA Clears Long Bridge Medical to Launch GOLDEN GATE Pivotal Trial for LensOne™ Prosthetic Capsular Bag Long Bridge Medical, Inc., a U.S.-based medical device innovator focused on advancing ophthalmic surgical solutions, has announced a major regulatory milestone with the U.S.…
Telemedicine Boosts Rural Hospitals’ Revenue and Care Access Rural healthcare in the United States is at a pivotal moment. Nearly one in five Americans—more than 60 million people—live in rural communities, where access to high-quality, specialized medical care remains a…
Brightseed Unveils First Clinically Validated Enterprise AI Platform Backed by 10+ Years of Scientific Research Brightseed is redefining the future of health sciences innovation with the launch of its groundbreaking enterprise AI platform—an integrated system designed to connect discovery, development,…